research

26 March, 2025

The Miguel Servet University Hospital in Zaragoza launches a pioneering program to assist patients with blindness.

The Excelsiov project, supported by Roche Farma, enables more efficient care for macular degeneration and diabetic macular edema. The IIS Aragón will analyze the program's results and disseminate the ophthalmological care model.
25 March, 2025

First Workshop on Bioanalysis and Clinical Diagnosis, with an Emphasis on Lyme Disease

The first workshop of the EFA2/99 Nanolyme project, funded by the European Interreg Poctefa program, can be followed next Wednesday, April 1nd, at the Río Ebro Campus and on YouTube. To attend, please complete a form.
20 March, 2025

The Aragon Health System Biobank launches its monthly newsletter

Published monthly, the newsletter will provide information of interest on the operation of the Biobank, the latest developments in the Biobank's work, and its collaboration with various IIS Aragón groups, among others.
20 March, 2025

Breastfeeding attenuates the genetic predisposition to obesity in adolescence

The 'Growth, exercise, nutrition and development (GENUD)' group (GIIS066) from the IIS Aragón and the University of Zaragoza has published a study in the journal Pediatric Obesity highlighting the protective role of breastfeeding against obesity, after analyzing data from 715 European adolescents.
19 March, 2025

Ignacio Ochoa Garrido: “Don't try to cure diseases on the first day; science is an endurance race.”

In this interview, IIS Aragón researcher talks about his work leading the Tissue Microenvironment Lab (TME Lab) (GIIS018) group and his lines of research.
14 March, 2025

Aragonese researchers discover a new marker for detecting cardiovascular risk in patients with sleep apnea.

The study is being promoted by the "Precision Medicine in Respiratory Diseases" (GIIS041) group at the IIS Aragón. The research focuses on how obstructive sleep apnea affects the heart and blood vessels.
25 February, 2025

Researchers from IIS Aragón and I3A create a microfluidic device to better understand the communication between a brain tumor and the immune system

The TME Lab research group has developed the new device that allows studying the interaction between tumor and immune cells. The scientific journal Nano-Micro Small has published the research.